{"slug":"pt-141-glp-1","verification":{"valid":true,"entries":2,"head":"faa3ed588a86463a41a4c49863219fd0db5c1e0589f0cbf154e7318053f7d05f"},"energy":{"passes":2,"tokens_in":19128,"tokens_out":3887,"tokens_total":23015,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"faa3ed588a86463a41a4c49863219fd0db5c1e0589f0cbf154e7318053f7d05f"},"provenance":[{"ts":"2026-06-30T01:17:05.301Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Glp 1\nSlug: pt-141-glp-1\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[\"glp1-agonists\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[{\"drug\":\"glp1-agonists\",\"name\":\"GLP-1 agonists (class)\",\"section_title\":\"Why GLP-1 agonists (class) matters for you\",\"steps\":[\"**Drug:** GLP-1 agonists (class)\",\"**What it does:** Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss.\",\"**Therefore for you:** state whether this drug **reduces load**, **suppresses a signal**, or **supports metabolism** — and whether that helps or trades off repair for your condition.\"],\"prose\":\"1. **Drug:** GLP-1 agonists (class)\\n2. **What it does:** Metabolic benefit vs gut slowing / muscle loss tradeoffs at rapid weight loss.\\n3. **Therefore for you:**","response":"{\n  \"slug\": \"pt-141-glp-1\",\n  \"title\": \"PT-141 and GLP-1 Agonists: Evidence-Graded Look at Combination Use\",\n  \"body\": \"## What's breaking down\\n\\nNo single disease profile is tied to the slug, but the cross points to two overlapping layers: metabolic regulation (appetite, weight, energy balance) and central nervous system arousal pathways (sexual desire via melanocortin receptors). GLP-1 agonists primarily act on metabolic and gut signals. PT-141 targets melanocortin-4 receptors (MC4R) in the brain. When these layers interact, the question becomes whether one pathway supports or trades off against the other.\\n\\n## Why PT-141 might help you\\n\\nPT-141 (bremelanotide) is discussed for the sexual / CNS arousal layer. If that layer is part of your problem while using GLP-1 agonists, the compound is examined because it engages central melanocortin pathways that influence desire and arousal rather than masking symptoms. Step one: MC4R activation occurs in brain regions tied to reward and sexual response. Step two: this occurs independently of blood-flow mechanisms used by PDE5 inhibitors. Step three: therefore, if GLP-1 use coincides with reduced desire reports, PT-141 is studied for its distinct central action on that specific layer.\\n\\n## Why GLP-1 agonists (class) matters for you\\n\\nGLP-1 agonists support metabolism through appetite reduction and improved glycemic control. This can reduce overall body weight, which in turn lowers mechanical stress on joints and the spine in weight-sensitive individuals. At the same time, rapid weight loss carries tradeoffs such as potential muscle loss or gut slowing. The class therefore primarily supports metabolic repair pathways while suppressing hunger signals. Whether this helps or trades off against other layers depends on the individual balance between sustained weight reduction and any reported shifts in energy or desire.\\n\\n## How these fit together\\n\\nSingle-compound focus applies here. PT-141 targets the sexual / CNS arousal","tokens_in":19128,"tokens_out":3887,"cost":0,"prev":"genesis","hash":"1c33a9cc3779f4d86686f3e0300eb96d8a2d1a3dc3289b47bd8e3f89773a88a5"},{"ts":"2026-07-17T02:41:06.022Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-glp-1","response":"23 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"1c33a9cc3779f4d86686f3e0300eb96d8a2d1a3dc3289b47bd8e3f89773a88a5","hash":"faa3ed588a86463a41a4c49863219fd0db5c1e0589f0cbf154e7318053f7d05f"}]}